Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study
CONCLUSIONS: Eupatilin administration for ≥ 3 months showed additional preventive effect on GI bleeding in concomitant aspirin and acid suppressant users. Thus, cotreatment with eupatilin with a duration of 3 months or longer is recommended for reducing GI bleeding among aspirin plus acid suppressant users.PMID:38092556 | DOI:10.3904/kjim.2023.324
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Hyun Seok Lee Ji Hyung Nam Dong Jun Oh Yeo Rae Moon Yun Jeong Lim Source Type: research
More News: Aspirin | Bleeding | Databases & Libraries | Gastroenterology | Health Insurance | Insurance | Internal Medicine | Statistics | Study